** = Publikationen gelistet in SCI/SSCI/Pubmed
** Edtmayer, S; Witalisz-Siepracka, A; Zdársky, B; Heindl, K; Weiss, S; Eder, T; Dutta, S; Graichen, U; Klee, S; Sharif, O; Wieser, R; Győrffy, B; Poli, V; Casanova, E; Sill, H; Grebien, F; Stoiber, D
A novel function of STAT3β in suppressing interferon response improves outcome in acute myeloid leukemia.
Cell Death Dis. 2024; 15(5): 369
Doi: 10.1038/s41419-024-06749-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Witalisz-Siepracka, A; Denk, CM; Zdársky, B; Hofmann, L; Edtmayer, S; Harm, T; Weiss, S; Heindl, K; Hessenberger, M; Summer, S; Dutta, S; Casanova, E; Obermair, GJ; Győrffy, B; Putz, EM; Sill, H; Stoiber, D
STAT3 in acute myeloid leukemia facilitates natural killer cell-mediated surveillance.
Front Immunol. 2024; 15: 1374068
Doi: 10.3389/fimmu.2024.1374068
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Cutillas, PR; Borek, WE; Christopher, JA; Nobre, LV; Campbell, A; Kelsall, J; Pedicona, F; Nawaz, N; Perkins, DN; Cardoso, PM; Arruda, A; Ambinder, AJ; Dutta, S; Gallipoli, P; Sill, H; Ghiaur, G; Minden, MD; Williamson, A; Gribben, JG; Dokal, AD
Multi-drug algorithm to accurately predict best first-line treatments in newly-diagnosed acute myeloid leukemia (AML)
J CLIN ONCOL. 2024; 42(16):
[Poster]
Web of Science
** Edtmayer, S; Witalisz-Siepracka, A; Zdársky, B; Weiss, S; Eder, T; Dutta, S; Wieser, R; Sill, H; Grebien, F; Stoiber, D
STAT3β represses interferon signaling in acute myeloid leukemia contributing to favorable disease outcomes
KLIN PADIATR. Abstracts. 2024; 236(3):204-204.-35. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch onkologische Forschung; JUN 5-8, 2024; Wilsede, GERMANY.
Doi: 10.1055/s-0044-1786570
[Poster]
Web of Science
FullText
FullText_MUG
** Dutta, S; Kerbs, P; Rothenberg-Thurley, M; Ksienzyk, B; Krebs, S; Blum, H; Spiekermann, K; Metzeler, KH; Herold, T; Dandachi, N; Vosberg, S; Greif, PA;
FREQUENT TRUNCATING MUTATIONS IN TET2 GENE AND A DISTINCT DNA METHYLATION SIGNATURE CHARACTERIZES ACUTE MYELOID LEUKEMIA WITH ISOLATED TRISOMY 4
ANN HEMATOL. 2023; 102(SUPPL 1):S26-S27.-ACUTE LEUKEMIAS XVIII .ISALXVIII
BIOLOGY AND TREATMENT STRATEGIES; March 19-20, 2023; Munich Germany.
[Poster]
Web of Science
** Lyssy, F; Lind, K; Zöscher, F; Zebisch, A; Wölfler, A; Pabst, G; Fosselteder, J; Reinisch, A; Sill, H; Dutta, S
Modelling drug resistance conferred by mono- and bi-allelic TP53 aberrations using isogenic AML cell lines
ONCOL RES TREAT. 2023; 46: 188-189.
[Poster]
Web of Science
FullText
** Dutta, S; Moritz, J; Pregartner, G; Thallinger, GG; Brandstätter, I; Lind, K; Rezania, S; Lyssy, F; Reinisch, A; Zebisch, A; Berghold, A; Wölfler, A; Sill, H
Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations.
Ann Hematol. 2022; 101(4):837-846
Doi: 10.1007/s00277-022-04766-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Jakel, H; Taschler, M; Jung, K; Weinl, C; Pegka, F; Kullmann, MK; Podmirseg, SR; Dutta, S; Moser, M; Hengst, L
Inability to phosphorylate Y88 of p27(Kip1) enforces reduced p27 protein levels and accelerates leukemia progression
LEUKEMIA. 2022;
Doi: 10.1038/s41375-022-01598-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Dutta, S; Kerbs, P; Rothenberg-Thurley, M; Ksienzyk, B; Krebs, S; Blum, H; Spiekermann, K; Metzeler, KH; Herold, T; Vosberg, S; Greif, PA
Acute Myeloid Leukemia with Isolated Trisomy 4 Is Characterized By Frequent Mutations of TET2 and a Distinct DNA Methylation Signature
BLOOD. 2022; 140: 8912-8913.-64th American Society of Hematology Annual Meeting and Exposition; December 10-13, 2022; New Orleans USA.
Doi: 10.1182/blood-2022-168939
[Poster]
Web of Science
FullText
FullText_MUG
** Dutta, S; Pregartner, G; Rücker, FG; Heitzer, E; Zebisch, A; Bullinger, L; Berghold, A; Döhner, K; Sill, H
Functional Classification of TP53 Mutations in Acute Myeloid Leukemia.
Cancers (Basel). 2020; 12(3):
Doi: 10.3390/cancers12030637
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Barbosa, K; Deshpande, A; Chen, BR; Ghosh, A; Sun, Y; Dutta, S; Weetall, M; Dixon, J; Armstrong, SA; Bohlander, SK; Deshpande, AJ
Acute myeloid leukemia driven by the CALM-AF10 fusion gene is dependent on BMI1.
Exp Hematol. 2019; 74: 42-51.e3.
Doi: 10.1016/j.exphem.2019.04.003
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Dutta, S; Krause, A; Vosberg, S; Herold, T; Ksienzyk, B; Quintanilla-Martinez, L; Tizazu, B; Chopra, M; Graf, A; Krebs, S; Blum, H; Greif, PA; Vetter, A; Metzeler, K; Rothenberg-Thurley, M; Schneider, MR; Dahlhoff, M; Spiekermann, K; Zimber-Strobl, U; Wolf, E; Bohlander, SK
The target cell of transformation is distinct from the leukemia stem cell in murine CALM/AF10 leukemia models.
Leukemia. 2016; 30(5): 1166-1176.
Doi: 10.1038/leu.2015.349
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hartmann, L; Dutta, S; Opatz, S; Vosberg, S; Reiter, K; Leubolt, G; Metzeler, KH; Herold, T; Bamopoulos, SA; Bräundl, K; Zellmeier, E; Ksienzyk, B; Konstandin, NP; Schneider, S; Hopfner, KP; Graf, A; Krebs, S; Blum, H; Middeke, JM; Stölzel, F; Thiede, C; Wolf, S; Bohlander, SK; Preiss, C; Chen-Wichmann, L; Wichmann, C; Sauerland, MC; Büchner, T; Berdel, WE; Wörmann, BJ; Braess, J; Hiddemann, W; Spiekermann, K; Greif, PA
ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation.
Nat Commun. 2016; 7(1): 11733-11733.
Doi: 10.1038/ncomms11733
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Viswanathan, G; Joshi, SV; Sridhar, A; Dutta, S; Raghunand, TR
Identifying novel mycobacterial stress associated genes using a random mutagenesis screen in Mycobacterium smegmatis.
Gene. 2015; 574(1): 20-7.
Doi: 10.1016/j.gene.2015.07.063
Web of Science
PubMed
FullText
FullText_MUG